Fortitude Advisory Group’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-393
Closed -$64K 307
2022
Q1
$64K Buy
393
+145
+58% +$23.5K 0.03% 451
2021
Q4
$47K Buy
+248
New +$47.8K 0.02% 564

Other funds holding BBH

Fortitude Advisory Group's BBH Position: Q2 2022 in Review

Fortitude Advisory Group sold out of VanEck Biotech ETF (BBH) in Q2 2022, closing a stake of 393 shares — an estimated $64K sold.

Fortitude Advisory Group first reported a position in BBH in Q4 2021 and held it in 2 quarters. The position peaked at $64K in Q1 2022. 108 funds tracked by Wall St. Rank hold BBH as of Q2 2022.

  • Fortitude Advisory Group reported no remaining VanEck Biotech ETF position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 393 VanEck Biotech ETF shares in Q2 2022, an estimated $64K.
  • Fortitude Advisory Group first reported a position in VanEck Biotech ETF in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's VanEck Biotech ETF position peaked at $64K in Q1 2022.
  • 108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.